April 2020 HSC Section 4 - Plastic and Reconstructive Problems

Annals of Plastic Surgery • Volume 83, Number 2, August 2019

Siotos et al

46. Patel PA , Bailey JK, Yakuboff KP, et al. Treatment outcomes for keloid scar man- agement in the pediatric burn population. Burns . 2012;38:767 – 771. 47. Kim HJ , Jung SK, Lee KG, et al. A comparative study on recurrence of earlobe keloids after postoperative adjuvant therapy. Korean J Dermatol . 2012;50: 768 – 772. 48. Carvalho B , Ballin AC, Becker RV, et al. Treatment of retroauricular keloids: revi- sion of cases treated at the ENT service of HC/UFPR. Int Arch Otorhinolaryngol . 2012;16:195 – 200. 49. Ozaki Y , Kakudo N, Minakata T, et al. Study of ear keloid treatment in our hospi- tal. Jpn J Plast Surg . 2010;53:1003 – 1008. 50. Cao CY , Shuai MS, Ding ZQ, et al. Clinical observation of the therapeutic efficacy of surgical excision combined with triamcinolone acetonide injection and 90 Sr- 90 Y applicator brachytherapy for the treatment of keloids. J Clin Dermatol . 2015;44:813 – 815. 51. Aluko-Olokun B , Olaitan AA, Ladeinde AL, et al. The facial keloid: a comparison of treatment outcome between intralesional steroid injection and excision com- bined with radiotherapy. Eur J Plast Surg . 2014;37:361 – 366. 52. Park TH , Chang CH. Location of keloids and its treatment modality may influence the keloid recurrence in children. J Craniofac Surg . 2015;26:1355 – 1357. 53. Davison SP , Mess S, Kauffman LC, et al. Ineffective treatment of keloids with in- terferon alpha-2b. Plast Reconstr Surg . 2006;117:247 – 252. 54. Ogawa R , Yoshitatsu S, Yoshida K, et al. Is radiation therapy for keloids accept- able? The risk of radiation-induced carcinogenesis. Plast Reconstr Surg . 2009; 124:1196 – 1201. 55. Kim J , Lee SH. Therapeutic results and safety of postoperative radiotherapy for keloid after repeated cesarean section in immediate postpartum period. Radiat Oncol J . 2012;30:49 – 52. 56. Lee SY , Park J. Postoperative electron beam radiotherapy for keloids: treatment outcome and factors associated with occurrence and recurrence. Ann Dermatol . 2015;27:53 – 58. 57. Mankowski P , Kanevsky J, Tomlinson J, et al. Optimizing radiotherapy for ke- loids: a meta-analysis systematic review comparing recurrence rates between dif- ferent radiation modalities. Ann Plast Surg . 2017;78:403 – 411. 58. Hoang D , Reznik R, Orgel M, et al. Surgical excision and adjuvant brachyther- apy vs external beam radiation for the effective treatment of keloids: 10-year insti- tutional retrospective analysis. Aesthet Surg J . 2017;37:212 – 225. 59. Viani GA , Stefano EJ, Afonso SL, et al. Postoperative strontium-90 brachytherapy in the prevention of keloids: results and prognostic factors. Int J Radiat Oncol Biol Phys . 2009;73:1510 – 1516. 60. Ogawa R , Huang C, Akaishi S, et al. Analysis of surgical treatments for earlobe keloids: analysis of 174 lesions in 145 patients. Plast Reconstr Surg . 2013;132: 818e – 825e. 61. Bock O , Schmid-Ott G, Malewski P, et al. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res . 2006;297:433 – 438. 62. Lumenta DB , Siepmann E, Kamolz LP. Internet-based survey on current practice for evaluation, prevention, and treatment of scars, hypertrophic scars, and keloids. Wound Repair Regen . 2014;22:483 – 491. 63. Ceilley RI . Mechanisms of action of topical 5-fluorouracil: review and implica- tions for the treatment of dermatological disorders. J Dermatolog Treat . 2012; 23:83 – 89.

25. Salanti G , Higgins JP, Ades AE, et al. Evaluation of networks of randomized trials. Stat Methods Med Res . 2008;17:279 – 301. 26. Jadad AR , Moore RA, Carroll D, et al. Assessing the quality of reports of random- ized clinical trials: is blinding necessary? Control Clin Trials . 1996;17:1 – 12. 27. Slim K , Nini E, Forestier D, et al. Methodological index for non-randomized stud- ies (minors): development and validation of a new instrument. ANZ J Surg . 2003; 73:712 – 716. 28. Review Manager (RevMan) [Computer Program] Version 5.3 . Copenhagen: The Nordic Cochrane Centre The Cochrane Collaboration; 2011. 29. DerSimonian R , Kacker R. Random-effects model for meta-analysis of clinical tri- als: an update. Contemp Clin Trials . 2007;28:105 – 114. 30. Higgins JP , Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-anal- yses. BMJ . 2003;327:557 – 560. 31. Higgins JPT , Green S. Cochrane Handbook for Systematic Reviews of Interven- tions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration . 2011. Available at: http://handbook.cochrane.org. 32. Hong H , Carlin BP, Shamliyan TA, et al. Comparing Bayesian and frequentist ap- proaches for multiple outcome mixed treatment comparisons. Med Decis Making . 2013;33:702 – 714. 33. Lu G , Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med . 2004;23:3105 – 3124. 34. Dias S , Welton NJ, Caldwell DM, et al. Checking consistency in mixed treatment comparison meta-analysis. Stat Med . 2010;29:932 – 944. 35. Salanti G , Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tu- torial. J Clin Epidemiol . 2011;64:163 – 171. 36. Valkenhoef GV , Kuiper J. gemtc: Network meta-analysis using Bayesian methods. R Package version 06-1 2014. Available at: http://CRAN.R-project.org/package1/ 4gemtc. Accessed June 1, 2018. 37. Gelman A , Rubin DB. Inference from iterative simulation using multiple se- quences. Stat Sci . 1992;7:457 – 472. 38. Carlin BP , Louis TA. Bayesian methods for data analysis. 3rd ed. Boca Raton, FL: Chapman & Hall/CRC; 2009:311 – 361. 39. Nason LH . Keloids and their treatment. N Engl J Med . 1942;226:883 – 886. 40. Sclafani AP , Gordon L, Chadha M, et al. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a random- ized, prospective study and review of the literature. Dermatol Surg . 1996;22: 569 – 574. 41. Berman B , Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol . 1997;37(5 Pt 1):755 – 757. 42. Guix B , Henríquez I, Andrés A, et al. Treatment of keloids by high-dose-rate brachytherapy: a seven-year study. Int J Radiat Oncol Biol Phys . 2001;50:167 – 172. 43. Jackson IT , Bhageshpur R, DiNick V, et al. Investigation of recurrence rates among earlobe keloids utilizing various postoperative therapeutic modalities. Eur J Plast Surg . 2001;24:88 – 95. 44. D'Andrea F , Brongo S, Ferraro G, et al. Prevention and treatment of keloids with intralesional verapamil. Dermatology . 2002;204:60 – 62. 45. Hatamipour E , Mehrabi S, Hatamipour M, et al. Effects of combined intralesional 5-fluorouracil and topical silicone in prevention of keloids: a double blind ran- domized clinical trial study. Acta Med Iran . 2011;49:127 – 130.

www.annalsplasticsurgery.com

© 2019 Wolters Kluwer Health, Inc. All rights reserved.

135